Clinical Trial Update: Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Naproxcinod for analgesic efficacy and safety in osteoarthritis of the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Naproxcinod (naproxcinod)

Snippet

Sponsor: NicOx | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED